Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis

Xia, J.H. et al. Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2–24.1. J. Invest. Dermatol. 114, 1071–1074 (2000). 10.1046/j.1523-1747.2000.00978.x

[6]

Anderson, D.E. & Chernosky, M.E. Disseminated superficial actinic porokeratosis. Genetic aspects. Arch. Dermatol. 99, 408–412 (1969). 10.1001/archderm.1969.01610220036006

[7]

Zhang, Z.H. et al. A mutation in SART3 gene in a Chinese pedigree with disseminated superficial actinic porokeratosis. Br. J. Dermatol. 152, 658–663 (2005). 10.1111/j.1365-2133.2005.06443.x

[8]

Xia, K. et al. A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1–26.1. Br. J. Dermatol. 147, 650–654 (2002). 10.1046/j.1365-2133.2002.05058.x

[9]

Liu, P. et al. Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3–p31.1. Hum. Genet. 123, 507–513 (2008). 10.1007/s00439-008-0504-x

[10]

Luan, J. et al. A novel locus for disseminated superficial actinic porokeratosis maps to chromosome 16q24.1–24.3. Hum. Genet. 129, 329–334 (2011). 10.1007/s00439-010-0929-x

[11]

Zhang, Z. et al. Fine mapping and identification of a candidate gene SSH1 in disseminated superficial actinic porokeratosis. Hum. Mutat. 24, 438 (2004). 10.1002/humu.9283

[12]

Frank, J., van Geel, M. & van Steensel, M.A. Loss of heterozygosity studies on chromosome 12q in disseminated superficial actinic porokeratosis: lessons to be learned. J. Invest. Dermatol. 127, 2058–2059 (2007). 10.1038/sj.jid.5700783

[13]

Frank, J., van Steensel, M.A. & van Geel, M. Lack of SSH1 mutations in Dutch patients with disseminated superficial actinic porokeratosis: is there really an association? Hum. Mutat. 28, 1241–1242 (2007). 10.1002/humu.20587

[14]

Targeted capture and massively parallel sequencing of 12 human exomes

Sarah B. Ng, Emily H. Turner, Peggy D. Robertson et al.

Nature 2009 10.1038/nature08250

[15]

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

K. Wang, M. Li, H. Hakonarson

Nucleic Acids Research 2010 10.1093/nar/gkq603

[16]

Cooper, G.M. et al. Single-nucleotide evolutionary constraint scores highlight disease-causing mutations. Nat. Methods 7, 250–251 (2010). 10.1038/nmeth0410-250

[17]

Wu, L.Q. et al. Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAP1) at 12q23.2–24.1. Br. J. Dermatol. 150, 999–1004 (2004). 10.1111/j.1365-2133.2004.05912.x

[18]

Fu, Z., Wang, M., Potter, D., Miziorko, H.M. & Kim, J.J. The structure of a binary complex between a mammalian mevalonate kinase and ATP: insights into the reaction mechanism and human inherited disease. J. Biol. Chem. 277, 18134–18142 (2002). 10.1074/jbc.m200912200

[19]

Houten, S.M., Wanders, R.J. & Waterham, H.R. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim. Biophys. Acta 1529, 19–32 (2000). 10.1016/s1388-1981(00)00135-9

[20]

McTaggart, S.J. Isoprenylated proteins. Cell. Mol. Life Sci. 63, 255–267 (2006). 10.1007/s00018-005-5298-6

[21]

Bouwstra, J.A. & Ponec, M. The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 1758, 2080–2095 (2006). 10.1016/j.bbamem.2006.06.021

[22]

Zhao, Y., Gartner, U., Smith, F.J. & McLean, W.H. Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J. Invest. Dermatol. 131, 1045–1052 (2011). 10.1038/jid.2011.41

[23]

Edmondson, S.R., Werther, G.A. & Wraight, C.J. Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 116, 491–497 (2001). 10.1046/j.0022-202x.2001.temp.doc.x

[24]

Shen, C.S. et al. Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis. Br. J. Dermatol. 147, 498–502 (2002). 10.1046/j.1365-2133.2002.04853.x

[25]

Haas, D. & Hoffmann, G.F. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J. Rare Dis. 1, 13 (2006). 10.1186/1750-1172-1-13

[26]

Cuisset, L. et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur. J. Hum. Genet. 9, 260–266 (2001). 10.1038/sj.ejhg.5200614

[27]

Mandey, S.H., Schneiders, M.S., Koster, J. & Waterham, H.R. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum. Mutat. 27, 796–802 (2006). 10.1002/humu.20361

[28]

Drenth, J.P., Haagsma, C.J. & van der Meer, J.W. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73, 133–144 (1994). 10.1097/00005792-199405000-00002

[29]

Cuisset, L. et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur. J. Hum. Genet. 9, 260–266 (2001). 10.1038/sj.ejhg.5200614

[30]

Bader-Meunier, B. et al. Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128, e152–e159 (2011). 10.1542/peds.2010-3639

[31]

SOAP: short oligonucleotide alignment program

Ruiqiang Li, Yingrui Li, Karsten Kristiansen et al.

Bioinformatics 2008 10.1093/bioinformatics/btn025

[32]

SOAP2: an improved ultrafast tool for short read alignment

Ruiqiang Li, Chang Yu, Yingrui Li et al.

Bioinformatics 2009 10.1093/bioinformatics/btp336

[33]

Li, R. et al. SNP detection for massively parallel whole-genome resequencing. Genome Res. 19, 1124–1132 (2009). 10.1101/gr.088013.108

[34]

Fast and accurate short read alignment with Burrows–Wheeler transform

Heng Li, Richard Durbin

Bioinformatics 2009 10.1093/bioinformatics/btp324

[35]

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Aaron McKenna, Matthew Hanna, Eric Banks et al.

Genome Research 2010 10.1101/gr.107524.110

Metrics

136

Citations

35

References

Details

Published: Sep 16, 2012
Vol/Issue: 44(10)
Pages: 1156-1160
License: View

Authors

Harbin Medical University

X

Xin Zhang

IBM Research - Thomas J. Watson Research Center

Y

Yun-Qing Ren

Department of Dermatology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310058, China

Department of Computational Medicine and Bioinformatics University of Michigan Ann Arbor Michigan; School of Computer Science and Engineering Nanjing University of Science and Technology Nanjing China

Department of Biochemistry University of Washington Washington Seattle 98195; Institute for Protein Design, University of Washington Washington Seattle 98195

From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) — both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) — both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children’s Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) — both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape...

Xi'an University of Architecture and Technology

Central Laboratory of Yan'an Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.; Yunnan Cell Biology and Clinical Translation Research Center, Kunming, Yunnan, People's Republic of China.; Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, Yunnan, People's Republic of China.

University of Basel

Xihua University

Chinese University of Hong Kong

School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240

H

Hui Li

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, United States

Liaoning University of Traditional Chinese Medicine

Soochow University

D. L. Farrens, K. Yang, H. G. Khorana, Departments of Biology and Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

J

Jie Wang

China National GeneBank, Beijing Genomics Institute (BGI)–Shenzhen, Shenzhen, 518083, China.; BGI Education Center,University of Chinese Academy of Sciences,Shenzhen, 518083, China.

University of California, San Francisco

Shenyang Pharmaceutical University

X

Xue-jun Zhang

Cite This Article

Sheng-Quan Zhang, Tao Jiang, Xin Zhang, et al. (2012). Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nature Genetics, 44(10), 1156-1160. https://doi.org/10.1038/ng.2409

Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis

You May Also Like